Globus Medical Inc (GMED)
Globus Medical Inc (GMED) is a Healthcare stock tracked by StreetAlpha. GMED reports earnings on Thu, Nov 5, 2026. The average 12-month price target from 6 analysts is $90.00, with a high of $100.00 and a low of $80.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (4 buy, 2 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in GMED, 100% of them bullish and 0% bearish. In the past 30 days there were 1 dark pool print totaling $1.3M, the largest $1.3M.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →Based on 6 analysts who set a price target on GMED in the past 90 days. The average target is $90.00, with a high of $100.00 and a low of $80.00.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 1 | RBC Capital | Maintained | Buy | $85 |
| Aug 7 | Wells Fargo | Maintained | Buy | $99 |
| Jul 28 | UBS | Initiated | Hold | $82 |
| Jul 16 | Truist Securities | Maintained | Buy | $100 |
| Jul 13 | RBC Capital | Maintained | Buy | $115 |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether GMED is in one of them and how their past GMED trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered GMED in an article yet. Here's the latest on the wider market.
For informational purposes only. Not financial advice. Options flow and dark pool data are delayed and may be incomplete.